Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2022 - 12 - 09 save search
Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Published: 2022-12-09 (Crawled : 17:00) - biospace.com/
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.8%
H: 0.4%
C: -0.24%
trials breast cancer negative
New Clinical Data for Zanidatamab in HER2+ /HR+ Metastatic Breast Cancer Presented Today at 2022 SABCS
Published: 2022-12-09 (Crawled : 17:00) - biospace.com/
ZYME | $8.555 -0.06% -0.06% 590K
|
Health Technology
|
| O: 2.26%
H: 13.54%
C: -7.32%
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 1.65%
H: 1.85%
C: -3.47%
sabcs breast cancer her2+ today her2- her2 metastatic breast cancer
Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
Published: 2022-12-09 (Crawled : 16:00) - biospace.com/
EXAS | $63.24 -0.46% -0.46% 1.2M
|
Health Technology
|
| O: -0.57%
H: 2.84%
C: -2.41%
sciences breast therapy cancer
Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Patients with Advanced Breast Cancer at the 2022 San Antonio Breast Cancer Symposium
Published: 2022-12-09 (Crawled : 16:00) - biospace.com/
CELC | $16.9 -1.97% -2.01% 90K
|
Commercial Services
|
| O: 3.25%
H: 1.02%
C: -4.77%
breast symposium results cancer study phase 2b
Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: 185.44%
H: 288.03%
C: 288.03%
arx788 treatment breast positive cancer her2- her2 metastatic breast cancer
Real-World Study Confirms Benefit of XARELTO® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
Published: 2022-12-09 (Crawled : 13:20) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.78%
xarelto cancer study
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model Myriad Genetics, Inc., a leader in genetic testing and preci...
Published: 2022-12-09 (Crawled : 13:00) - biospace.com/
SXT | $70.03 0.2% 0.0% 1.3M
|
Distribution Services
|
| O: -0.42%
H: 0.97%
C: -0.33%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
TRIB | $1.83 -3.87% 11K
|
Health Technology
|
| O: -1.56%
H: 1.58%
C: -1.75%
REPL | $6.32 -1.56% -1.58% 630K
|
Health Technology
|
| O: -0.25%
H: 5.25%
C: 4.17%
MYGN | $18.61 0.05% 0.05% 480K
|
Health Technology
|
| O: -0.67%
H: 1.39%
C: -2.69%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: -0.19%
H: 0.77%
C: -0.77%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
APM | $5.69 3.45% 3.34% 17K
|
Health Technology
|
| O: -16.14%
H: 19.24%
C: 14.67%
risk breast genetic cancer study
Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting Presentations Featuring OGM Utility Across Blood Cancer Research Applications
Published: 2022-12-09 (Crawled : 02:00) - globenewswire.com
BNGO | $0.7655 -3.64% -3.78% 790K
|
Health Technology
|
| O: 0.46%
H: 1.38%
C: -2.3%
blood research meeting genomics cancer
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model
Published: 2022-12-09 (Crawled : 01:00) - globenewswire.com
MYGN | $18.61 0.05% 0.05% 480K
|
Health Technology
|
| O: -0.67%
H: 1.39%
C: -2.69%
risk breast cancer study
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.